Table 2.

Cell surface marker analysis of leukemic cells obtained from thymus, spleen, and bone marrow of TEL-JAK2 transgenic animals

Thymus Mice CD4+CD8+CD4+/CD8+
 60T1 (control) 28% 9% 59% 
 60 3.5%  36%  54%  
 65  9% 14.5%  67%  
 71-2 (control) 15% 10% 59% 
 71-4  3%  52%  40% 
 71-11  11%  30%  50% 
 71-24  4%  65% 18.5% 
Thymus Mice CD4+CD8+CD4+/CD8+
 60T1 (control) 28% 9% 59% 
 60 3.5%  36%  54%  
 65  9% 14.5%  67%  
 71-2 (control) 15% 10% 59% 
 71-4  3%  52%  40% 
 71-11  11%  30%  50% 
 71-24  4%  65% 18.5% 
Spleen Mice Thy1.2+CD4+CD8+CD4+/CD8+
 3-1-4 (control) 40% ND ND ND 
 3-1-8  60% ND  ND  ND  
 60T1 (control) 19% 11.5% 5% 1.5% 
 60  75%  3.5%  51%  15% 
 65  37%  3.5%  21%  8% 
 71-2 (control) 24% 14% 8% 0.6% 
 71-4  68% 15%  36.5%  22%  
Bone Marrow  Mice  Thy1.2+ CD4+ CD8+ CD4+/CD8+ 
 3-1-4 (control) 5% 2% 2% 0% 
 3-1-8  21%  3.5% 17%  0%  
 60T1 (control) 5% 3% 0% 0.5% 
 60 14%  5%  2%  8%  
 65 12%  4%  2%  2% 
 71-2 (control) 2.7% 4% 1.6% 0% 
 71-4  21%  6% 6%  13% 
Spleen Mice Thy1.2+CD4+CD8+CD4+/CD8+
 3-1-4 (control) 40% ND ND ND 
 3-1-8  60% ND  ND  ND  
 60T1 (control) 19% 11.5% 5% 1.5% 
 60  75%  3.5%  51%  15% 
 65  37%  3.5%  21%  8% 
 71-2 (control) 24% 14% 8% 0.6% 
 71-4  68% 15%  36.5%  22%  
Bone Marrow  Mice  Thy1.2+ CD4+ CD8+ CD4+/CD8+ 
 3-1-4 (control) 5% 2% 2% 0% 
 3-1-8  21%  3.5% 17%  0%  
 60T1 (control) 5% 3% 0% 0.5% 
 60 14%  5%  2%  8%  
 65 12%  4%  2%  2% 
 71-2 (control) 2.7% 4% 1.6% 0% 
 71-4  21%  6% 6%  13% 

Single-cell suspensions were obtained from the indicated organs of founder mice 60 and 65, F1 transgenic mice 71-4, 71-11, and 71-24, and F2 transgenic mouse 3-1-8 and analyzed by flow cytometry for the expression of the indicated markers. Age-matched nontransgenic littermate controls are shown in italics. ND indicates no data.

Close Modal

or Create an Account

Close Modal
Close Modal